Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SIN3 transcription regulator family member A (SIN3A) is a large, highly conserved transcriptional co-regulator that acts as the central scaffold subunit of the multi-protein SIN3/HDAC histone deacetylase complex. It contains several paired amphipathic helix (PAH) domains and interacts with diverse chromatin-modifying enzymes, including HDAC1/2, and multiple transcription factors such as REST and MXD1-MAX heterodimers for gene repression. SIN3A complexes modulate gene expression by remodeling chromatin through histone deacetylation, and their genome-wide occupancy is found at many active promoters. The protein displays dual activity, functioning as both a transcriptional repressor and an activator depending on complex context and interacting partners. SIN3A is essential for vital biological processes, including regulation of the cell cycle, pluripotency, neuronal differentiation, circadian rhythms, and the transcriptional response to hypoxia. Germline mutations or deletions in SIN3A cause neurodevelopmental disorders like Witteveen-Kolk syndrome and are associated with chromosome 15q24 deletion syndrome. SIN3A-containing complexes are implicated in cancer, particularly through their regulation of MYC and cell cycle genes. While currently not a direct drug target, the essential role of SIN3A in chromatin regulation makes it a critical node in gene regulatory networks with both therapeutic promise and toxicity risk if modulated
Indirect mechanisms only—HDAC inhibitors disrupt the SIN3A-containing complexes by inhibiting their core enzymatic (HDAC1/2) activity, affecting gene repression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SIN3 transcription regulator family member A (SIN3A).